Key Takeaways
- Sebuah meta-analisis dari beberapa RCT menemukan bahwa nattokinase secara signifikan menurunkan tekanan darah sistolik (-3,45 mmHg) dan tekanan darah diastolik (-2,32 mmHg), dengan satu uji coba menunjukkan efek tekanan darah yang lebih kuat khususnya pada pria.
- Sebuah studi klinis dengan 1.062 peserta menunjukkan bahwa nattokinase secara efektif mengelola perkembangan aterosklerosis dan memperbaiki profil lipid pada 84-95% peserta selama 12 bulan.
- Dosis uji klinis berkisar dari 2.000 FU (tekanan darah) hingga 6.000 FU (lipid), dengan Asosiasi Nattokinase Jepang merekomendasikan 2.000 FU/hari sebagai asupan standar
- Nattokinase umumnya ditoleransi dengan baik dalam uji klinis tetapi tidak boleh dikombinasikan dengan pengencer darah (warfarin, aspirin) tanpa pengawasan medis karena efek fibrinolitik tambahan.
- Penelitian Jepang mengungkap standar kualitas, teknologi penghilangan vitamin K2, dan formulasi sinergis yang sering diabaikan oleh sebagian besar panduan internasional
Heart disease remains the leading cause of death for men worldwide — and men tend to develop cardiovascular problems a full decade earlier than women. Yet most men don't discover nattokinase until they're already managing high blood pressure, elevated cholesterol, or poor circulation.
If you've heard about this enzyme from Japanese fermented soybeans, you've probably noticed a problem: almost every guide out there covers nattokinase generically. Very few address what nattokinase specifically means for men's health — even though emerging clinical data suggests men may respond to it differently than women.
We reviewed the clinical research, including a systematic review and meta-analysis of randomized controlled trials, multiple RCTs totaling over 1,500 participants, and Japanese clinical studies rarely cited in English-language guides. This guide breaks down the evidence for each benefit, explains what the research actually shows (and where the gaps are), and helps you decide if nattokinase belongs in your health routine.
What Is Nattokinase?
Nattokinase is a fibrinolytic enzyme produced during the fermentation of soybeans into natto, a traditional Japanese food that has been consumed for centuries. The enzyme was identified by Dr. Hiroyuki Sumi while researching at the University of Chicago, when he discovered that natto could dissolve artificial fibrin — the protein mesh that forms blood clots — with remarkable efficiency [6].
Despite its name, nattokinase is not actually a kinase enzyme. It's a subtilisin-like serine protease — a type of protein-digesting enzyme with 275 amino acids and a molecular weight of approximately 28 kDa. Its activity is measured in FU (fibrinolytic units), a standardized measurement established by the Japan Nattokinase Association (JNKA).
Natto vs. Nattokinase Supplements
Eating natto and taking nattokinase supplements are not the same thing. Natto contains nattokinase but also includes vitamin K2 (menaquinone-7), which promotes blood clotting — the opposite effect of nattokinase. This creates a contradiction: natto's fibrinolytic enzyme works against clotting while its vitamin K2 promotes it.
Japanese manufacturers solved this by developing extraction processes that isolate nattokinase while removing vitamin K2. Products like NSK-SD (a branded nattokinase extract) undergo specific purification to eliminate K2, making the supplement suitable for people who need to avoid vitamin K interference — including those on anticoagulant medications [21].
Why Men Should Pay Attention to Nattokinase
Men's Cardiovascular Risk Profile
The statistics for men's heart health are stark. Cardiovascular disease claims more male lives than any other cause, and men typically develop CVD approximately seven to ten years earlier than women. Hypertension is more prevalent in men under 65 than in women of the same age, and arterial stiffness — a key predictor of cardiovascular events — accelerates in men from their 40s onward.
These aren't just background statistics. They define the specific risk factors that nattokinase has been studied for: blood pressure, arterial health, blood clot prevention, and lipid management.
The Sex-Specific Blood Pressure Finding
One of the most relevant findings for men comes from a randomized, double-blind, placebo-controlled trial conducted in North America. Among 79 participants who took nattokinase (2,000 FU/day) for eight weeks, the blood pressure reduction was more pronounced in male participants. Specifically, men's diastolic blood pressure dropped from 86 mmHg to 81 mmHg (P<0.006 vs. placebo) — a clinically meaningful reduction. This effect was associated with changes in von Willebrand factor, a protein involved in blood clotting and vascular health [5].
This is one of the few studies to report sex-specific subgroup analysis for nattokinase, and it suggests that men may be particularly responsive to its vascular effects.
Evidence-Based Benefits for Men's Health
Blood Pressure Reduction: Strong Evidence
Blood pressure support is nattokinase's most well-documented benefit, backed by multiple randomized controlled trials and a systematic review.
A randomized controlled trial with 86 participants with pre-hypertension or stage-1 hypertension found that nattokinase supplementation for eight weeks significantly reduced systolic blood pressure by 9.1% and diastolic blood pressure by 6% compared to placebo [4].
A systematic review and meta-analysis pooling data from multiple RCTs confirmed these findings, reporting average reductions of 3.45 mmHg (systolic) and 2.32 mmHg (diastolic) [1]. While these numbers may seem modest, they're comparable to lifestyle interventions like reducing sodium intake, and for men with borderline or elevated blood pressure, they could make a meaningful difference in long-term cardiovascular risk.
Atherosclerosis and Arterial Health: Strong Evidence
A clinical study with 1,062 participants followed over 12 months found that nattokinase supplementation effectively managed atherosclerosis progression. The study reported that plaque did not advance during the treatment period, and lipid profiles improved significantly. Benefits were most pronounced in higher-risk groups, including smokers and those with elevated BMI — demographics that overlap heavily with men at cardiovascular risk [2].
A separate 26-week trial with 76 patients found that higher-dose nattokinase (6,500 FU/day) reduced carotid intima-media thickness and plaque size — direct measures of arterial health [6].
Important context: A three-year randomized controlled trial (the NAPS study) with 265 individuals without clinical cardiovascular disease did not find significant reduction in subclinical atherosclerosis or blood pressure at 2,000 FU/day [3]. This suggests nattokinase's benefits may be more pronounced in those who already have risk factors — which, for men over 40, is common.
Cholesterol and Lipid Management: Moderate Evidence
Multiple trials support nattokinase's effects on blood lipids, though results are dose-dependent.
The 1,062-participant study reported that 84-95% of participants showed improved lipid profiles over 12 months, including reductions in total cholesterol, LDL-C, and triglycerides, with HDL-C increasing by 15.8% (P<0.01) [2].
A randomized, double-blind, placebo-controlled trial combining nattokinase with red yeast rice in patients with stable coronary artery disease found significant reductions in triglycerides (-0.39 mmol/L), total cholesterol (-0.66 mmol/L), and increased HDL-C (+0.195 mmol/L) compared to placebo [7].
A comprehensive review of nattokinase lipid-lowering effects notes the recommended dose for lipid maintenance is 2,000-4,000 FU daily [11].
Blood Clot Prevention and Circulation: Strong Evidence
Nattokinase's original claim to fame — its ability to support healthy blood clot breakdown — remains its most consistent finding across studies.
A Japanese clinical trial involving 10 healthy adult males demonstrated that oral nattokinase administration produced significant increases in D-dimer (a marker of clot breakdown) and antithrombin concentration, with prolonged activated partial thromboplastin time (APTT) — all indicating enhanced fibrinolytic activity [15].
An eight-week trial with 45 participants taking 4,000 FU/day confirmed reductions in fibrinogen and factor VII, two key clotting factors, independent of participants' baseline health status [6].
For men, healthy circulation matters beyond cardiovascular disease prevention. Blood flow affects everything from exercise recovery to cognitive sharpness to sexual function. While no clinical trials have specifically tested nattokinase for erectile function, the enzyme's documented effects on blood flow and vascular health address several of the same circulatory factors that contribute to men's sexual health.
Brain Health: Emerging Evidence
Research on nattokinase's neuroprotective effects is still mostly preclinical, but the findings are intriguing.
Laboratory and animal studies show nattokinase can degrade amyloid-beta peptides — the protein fragments implicated in Alzheimer's disease — both in vitro and in living organisms [12]. Additional studies demonstrate neuroprotective effects against inflammation-driven brain damage and blood-brain barrier dysfunction [13].
The first randomized controlled trial evaluating nattokinase for cognition in patients with asymptomatic intracranial or carotid stenosis found it did not improve global cognition but showed potential improvement in visuospatial function [9]. This is honest, nuanced evidence — not a breakthrough, but a signal worth monitoring.
Anti-Inflammatory Properties: Emerging Evidence
Nattokinase demonstrates anti-inflammatory and antioxidant effects in preclinical research. One study found it attenuated hepatic and neural toxicity through activation of the Nrf2 pathway and suppression of inflammatory mediators [14]. A comprehensive review positions nattokinase as an adjuvant therapeutic strategy for non-communicable diseases, citing its anti-inflammatory and antioxidant properties alongside its better-established fibrinolytic effects [10].
For men, chronic low-grade inflammation is increasingly recognized as a driver of age-related health decline, including cardiovascular disease and metabolic dysfunction. However, most anti-inflammatory evidence for nattokinase comes from animal models, so these benefits should be considered supportive rather than primary.
How Nattokinase Works in the Body
Nattokinase operates through several complementary mechanisms that together support cardiovascular health:
Direct fibrinolysis. Nattokinase directly breaks down fibrin, the protein mesh that forms the structural basis of blood clots. It acts similarly to plasmin, the body's own clot-dissolving enzyme, but with broader substrate specificity.
t-PA enhancement. Nattokinase stimulates tissue plasminogen activator (t-PA), the enzyme responsible for converting plasminogen to plasmin. This amplifies the body's natural fibrinolytic capacity beyond what nattokinase achieves directly.
Clotting factor reduction. Clinical trials show nattokinase reduces levels of fibrinogen and factor VII — two proteins essential for clot formation [6].
Blood pressure modulation. Nattokinase exhibits ACE-inhibiting activity, similar to the mechanism of commonly prescribed ACE inhibitor medications. It also reduces von Willebrand factor, which contributes to blood viscosity [5].
Lipid effects. At higher doses, nattokinase appears to reduce total cholesterol, LDL-C, and triglycerides while raising HDL-C, though the mechanisms are less well understood than its fibrinolytic effects.
Importantly, nattokinase's safety margin has been reported as three times higher than pharmaceutical tissue plasminogen activators (tPA drugs used in emergency stroke treatment), suggesting a more gentle fibrinolytic action [1].
Dosage, Timing, and How to Take It
Recommended Dosage
Clinical trials have tested nattokinase across a range of doses, with benefits observed at different thresholds for different outcomes:
| Dosage (FU/day) | Primary Evidence | Duration Studied |
|---|---|---|
| 2,000 FU | Blood pressure reduction, vWF reduction | 8 weeks |
| 4,000 FU | Reduced clotting factors (fibrinogen, factor VII) | 8 weeks |
| 6,000-6,500 FU | Lipid improvement, atherosclerosis management | 26-52 weeks |
The Japan Nattokinase Association recommends 2,000 FU/day as the standard intake for general cardiovascular support. For context, this is equivalent to approximately 100mg of nattokinase extract, though exact conversion depends on the purity of the extract.
When to Take Nattokinase
Some researchers suggest taking nattokinase in the evening or before bed. The rationale: cardiovascular events like heart attacks and strokes peak in the early morning hours, and nattokinase's fibrinolytic activity could provide overnight vascular support during this higher-risk window. However, this timing recommendation is based on physiological reasoning rather than comparative clinical trials, so taking it at whatever time supports consistency is reasonable.
Nattokinase can be taken with or without food. Some evidence suggests food may support absorption, but clinical trials have not consistently controlled for this variable.
How Long Until Results?
Different effects have different timelines:
- Fibrinolytic markers: Changes detectable within hours of a single dose
- Blood pressure: Significant reductions typically observed after 4-8 weeks of daily use
- Lipid improvements: Most studies show meaningful changes at 12-26 weeks
- Arterial health: Long-term effects studied over 6-12 months
Consistency matters more than timing. The benefits accumulate with regular daily use.
Safety Considerations for Men
Overall Safety Profile
Nattokinase has demonstrated a favorable safety profile across multiple clinical trials. No serious adverse events have been reported at doses up to 6,500 FU/day in studies lasting up to 12 months. Toxicology studies confirm no adverse effects at doses up to 10 mg/kg/day for 28 days in humans, and no liver, kidney, or genotoxicity concerns in standard testing [6].
A Japanese safety study (registered under UMIN000017512) tested NSK-SD nattokinase extract at five times the recommended daily dose in healthy adults aged 20-64 and confirmed safety [16].
Possible Side Effects
Side effects are uncommon and generally mild when reported:
- Mild gastrointestinal discomfort (rare)
- Potential for increased bleeding risk at high doses or in sensitive individuals
- Rare allergic reactions (related to soy protein, not nattokinase itself)
Drug Interactions — Critical for Men
Many men over 40 take one or more cardiovascular medications. Understanding nattokinase's interactions is essential:
| Medication Type | Interaction Risk | Recommendation |
|---|---|---|
| Blood thinners (warfarin, heparin) | Additive fibrinolytic effects — increased bleeding risk | Consult physician before combining. One study of 153 patients found no adverse interactions at 100mg/day with enoxaparin/fondaparinux, but medical supervision is essential [18] |
| Antiplatelet drugs (aspirin, clopidogrel) | Potential additive anticoagulant effect | Medical supervision required |
| Blood pressure medications | Possible additive hypotensive effect | Monitor blood pressure closely; meta-analysis shows -3.45/-2.32 mmHg reduction [1] |
| Statins | No safety issues identified in combination trials | A 90-day trial combining nattokinase with red yeast rice showed no adverse effects [7] |
| ED medications | No direct interaction data | Both affect blood flow; consult physician before combining |
Who Should Avoid Nattokinase
- People with bleeding disorders — nattokinase's fibrinolytic activity could worsen bleeding
- Anyone scheduled for surgery — discontinue at least two weeks before procedures
- People with soy allergies — nattokinase is derived from soy fermentation
- Those on anticoagulant therapy without medical supervision — the combination requires professional monitoring
- Pregnant or nursing women — insufficient safety data in these populations
Realistic Expectations
Nattokinase is not a medication. It will not replace prescribed blood pressure drugs, statins, or anticoagulants. The clinical evidence supports it as a complementary approach — something that works alongside (not instead of) medical treatment and healthy lifestyle choices. The most honest summary: nattokinase offers modest but measurable cardiovascular support, particularly for blood pressure and fibrinolytic activity, and the effects are enhanced with consistent daily use over months.
What Japanese Research Reveals That Most Guides Miss
JNKA: A Quality Standard Most Consumers Don't Know Exists
The Japan Nattokinase Association (JNKA) has established standardized quality criteria for nattokinase products, including a certified measurement protocol for FU (fibrinolytic units). This matters because without standardization, "nattokinase" could mean very different things across products. JNKA-certified products undergo testing to verify their actual fibrinolytic activity matches label claims [21].
Why this matters: When choosing a nattokinase supplement, look for JNKA-standard FU measurements. A product claiming "2,000 FU" without referencing a validated testing method may not deliver the activity you expect.
The Vitamin K2 Removal Innovation
Japanese manufacturers recognized a fundamental contradiction in natto: the food contains both nattokinase (which supports healthy blood flow) and vitamin K2 (which promotes clotting). For people taking anticoagulant medications, this combination is problematic. Japanese extraction technology — notably the NSK-SD process — specifically removes vitamin K2 from nattokinase supplements while preserving the enzyme's fibrinolytic activity [16].
A JNKA-sponsored study confirmed that appropriate nattokinase doses in cardiovascular patients already taking warfarin produced stable coagulation parameters with no adverse effects — a finding that challenges the blanket advice to "avoid nattokinase if you take blood thinners" [21].
Why this matters: Not all nattokinase supplements remove vitamin K2. If you take anticoagulant medications, Japanese supplements with K2 removal (like NSK-SD-based products) offer a documented safety advantage.
Synergistic Formulations vs. Single-Ingredient Approaches
While most international nattokinase supplements contain nattokinase alone, Japanese manufacturers often take a multi-ingredient approach. For example, Kobayashi Pharmaceutical's Nattokinase EX combines nattokinase with EPA, DHA, sardine peptides (containing valytyrosine for ACE-inhibiting activity), and tochu leaf extract (for vascular flexibility). Each ingredient targets a different cardiovascular pathway.
This reflects a broader pattern in Japanese supplement design: rather than isolating a single active compound, formulations combine multiple ingredients that address the same health concern through complementary mechanisms.
Why this matters: A synergistic formula may address cardiovascular health more comprehensively than nattokinase alone, though head-to-head clinical comparisons between single-ingredient and multi-ingredient nattokinase products are limited.
Japanese Safety Testing Goes Further Than Standard
Japanese clinical trials on nattokinase include overdose safety studies — specifically testing five times the recommended dose in healthy adults to confirm safety margins [16]. Additionally, Japanese trials have registered warfarin co-administration studies to establish practical guidelines for patients on anticoagulant therapy, rather than simply advising avoidance.
This level of systematic safety investigation provides a more nuanced picture than the typical "avoid if taking blood thinners" guidance found in most international resources.
Why this matters: Japanese research provides specific safety parameters (dose limits, drug co-administration data) rather than blanket warnings, giving healthcare providers better information for patient-specific decisions.
Natto Consumption and Cardiovascular Health in Japan
Japan consistently ranks among the highest in the world for male life expectancy. While this is attributable to many dietary and lifestyle factors, regional data within Japan hints at a natto connection: areas with higher natto consumption tend to have lower cardiovascular mortality rates. However, these are observational associations with significant confounding factors — natto-consuming regions may also have other dietary and lifestyle patterns that contribute to better health outcomes.
Why this matters: The epidemiological data provides context but not proof. It's one piece of a larger puzzle that includes clinical trial evidence. Be cautious of claims that natto "explains" Japanese longevity — the reality is more complex.
Our Recommendations
We carry three nattokinase products, each suited to different needs. All are from established Japanese manufacturers with documented quality standards.
Kobayashi Nattokinase EX (30-Day Supply)
Why We Selected This: From Kobayashi Pharmaceutical, one of Japan's most established healthcare companies. We chose this for men who want comprehensive cardiovascular support because it combines nattokinase (2,500 FU) with EPA (13mg), DHA (72mg), sardine peptides, and tochu leaf extract — addressing circulation, blood lipids, blood pressure, and vascular flexibility through multiple pathways. The vitamin K2 has been removed from the nattokinase extract.
This multi-ingredient approach mirrors the synergistic formulation philosophy we highlighted in the Japanese research section. For men looking at overall cardiovascular maintenance rather than maximum nattokinase potency alone, this is our primary recommendation.
View Kobayashi Nattokinase EX →
ORIHIRO Nattokinase 4000
Why We Selected This: From ORIHIRO, a trusted Japanese supplement manufacturer. We chose this for men who want maximum nattokinase potency — 4,000 FU per daily serving. This dosage matches the level used in clinical trials demonstrating significant reductions in clotting factors (fibrinogen, factor VII). A straightforward, high-potency option for those who prefer a focused, single-purpose nattokinase supplement.
View ORIHIRO Nattokinase 4000 →
Noguchi Nattokinase HQ 4000FU
Why We Selected This: From the Noguchi Medical Research Institute, a name associated with medical-grade quality standards. We chose this for men who prioritize research credentials — the Noguchi name carries weight in Japanese healthcare. At 4,000 FU per serving, it matches the clinical trial dosage for fibrinolytic effects.
View Noguchi Nattokinase HQ 4000FU →
Product Comparison
| Feature | Kobayashi Nattokinase EX | ORIHIRO Nattokinase 4000 | Noguchi Nattokinase HQ |
|---|---|---|---|
| FU per serving | 2,500 FU | 4,000 FU | 4,000 FU |
| Additional ingredients | EPA, DHA, sardine peptides, tochu leaf extract | Focused nattokinase | Focused nattokinase |
| Vitamin K2 removed | Yes | Check label | Check label |
| Best for | Comprehensive cardiovascular support | Maximum nattokinase potency | Research-backed quality |
| Serving size | 2 capsules/day | Per label | Per label |
| Supply | 30 days | 30 days | 30 days |
Conclusion
Nattokinase offers men a well-researched, evidence-based approach to cardiovascular support. The strongest evidence points to meaningful blood pressure reduction — with data suggesting men may respond more robustly than the general population — along with fibrinolytic activity that supports healthy circulation and arterial health maintenance over time.
The evidence is encouraging but honest: nattokinase is not a medication replacement, and its effects are modest rather than dramatic. What sets it apart is its multi-mechanism approach to cardiovascular health, its strong safety profile, and the depth of Japanese research that reveals quality standards and formulation innovations most international guides overlook.
For men over 40 managing blood pressure, monitoring cholesterol, or simply investing in long-term cardiovascular health, nattokinase deserves consideration — ideally in conversation with your healthcare provider, especially if you take any medications.
This article is for informational purposes only and does not constitute medical advice. Consult a healthcare professional before starting any supplement regimen, especially if you have existing health conditions or take medications. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.
Frequently Asked Questions
- Suplemen Nattokinase dan faktor risiko kardiovaskular: tinjauan sistematis dan meta-analisis dari uji coba terkontrol secara acak (RCT)
- Manajemen efektif progres aterosklerosis dan hiperlipidemia dengan nattokinase: Studi klinis dengan 1.062 peserta
- Studi pencegahan aterotrombotik Nattokinase: Uji coba terkontrol secara acak
- Efek nattokinase pada tekanan darah: uji coba acak terkontrol
- Konsumsi nattokinase dikaitkan dengan penurunan tekanan darah dan faktor von Willebrand
- Nattokinase: Alternatif Menjanjikan dalam Pencegahan dan Pengobatan Penyakit Kardiovaskular
- Efek penurun lipid, antihipertensi, dan antitrombotik dari nattokinase yang dikombinasikan dengan beras ragi merah
- Efek suplemen Nattokinase-Monascus pada dislipidemia
- Suplemen Nattokinase untuk peningkatan kognitif pada stenosis intrakranial/karotis tanpa gejala
- Nattokinase sebagai strategi terapi tambahan untuk penyakit tidak menular
- Kemajuan penelitian nattokinase dalam mengurangi lipid darah
- Degradasi peptida amyloid β yang dikatalisis oleh nattokinase secara in vivo dan in vitro
- Nattokinase sebagai agen terapeutik potensial untuk mencegah disfungsi penghalang darah-otak
- Nattokinase mengurangi toksisitas hati dan saraf yang disebabkan oleh bisfenol A atau iradiasi gamma
- Uji Klinis Jepang — Pemberian oral NK pada pria sehat
- Uji Keamanan Jepang — Studi keamanan dosis 5× NSK-SD
- Efektivitas kardioprotektif komparatif: NOAC vs. Nattokinase
- Keamanan nattokinase dengan antikoagulan pada pasien penyakit pembuluh darah
- Efek Nattokinase pada Peningkatan Aliran Darah pada Subjek Sehat


